Denali Advisors LLC Lantheus Holdings, Inc. Transaction History

Denali Advisors LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 20, 2021	SELL	$10.75 - $14.91 $240,800 - $333,984	-22,400 Closed	0 $0
Q3 2020 Oct 16, 2020	SELL	$11.98 - $16.34 $17,371 - $23,693	-1,450 Reduced 6.08%	22,400 $284,000
Q2 2020 Jul 23, 2020	BUY	$10.34 - $15.51 $246,609 - $369,913	23,850 New	23,850 $341,000

540

68M

679K

423K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $6.28B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Denali Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Denali Advisors LLC with notifications on news.